Sign in
Explore the registryTrack Adagrasib's trials

CIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer

AdagrasibOngoingNot yet recruitingPhase 2Open NCT07543172 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07543172 · Trial Tracker · ComplyRx